Vimarsana
Biggest News Aggregation in the World

Atom Mines News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Atom Mines. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Atom Mines Today - Breaking & Trending Today

$63M grant funds OK'd to bring cancer research, treatment to Texas - Vimarsana News

$63M grant funds OK'd to bring cancer research, treatment to Texas

The oversight committee of the Cancer Prevention and Research Institute of Texas (CPRIT) approved $63 million in grant allocation Wednesday to help "bring innovative researchers and companies to Texas."

Source: kxan.com
$63M grant funds OK'd to bring cancer research, treatment to Texas - Vimarsana News

$63M grant funds OK'd to bring cancer research, treatment to Texas

The oversight committee of the Cancer Prevention and Research Institute of Texas (CPRIT) approved $63 million in grant allocation Wednesday to help "bring innovative researchers and companies to Texas."

Source: yahoo.com
Eckert & Ziegler to Supply Canadian Alpha-9 Theranostics with Lutetium-177 for Clinical Trials - Vimarsana News

Eckert & Ziegler to Supply Canadian Alpha-9 Theranostics with Lutetium-177 for Clinical Trials

DGAP-News: Eckert & Ziegler Strahlen- und Medizintechnik AG / Key word(s): Incoming Orders/Contract23.03.2022 / 10:16 The issuer is solely responsible for the content of this announcement.Berlin, 23 March 2022. Eckert & Ziegler (ISIN DE0005659700, TecDAX) has executed with the Canadian biotech company Alpha-9 Th...

DGAP-News: Eckert & Ziegler to Supply Canadian Alpha-9 Theranostics with Lutetium-177 for Clinical Trials Seite 1 - Vimarsana News

DGAP-News: Eckert & Ziegler to Supply Canadian Alpha-9 Theranostics with Lutetium-177 for Clinical Trials Seite 1

23.03.2022 - DGAP-News: Eckert & Ziegler Strahlen- und Medizintechnik AG / Key word(s): Incoming Orders/Contract Eckert & Ziegler to Supply Canadian Alpha-9 Theranostics with Lutetium-177 for Clinical Trials 23.03.2022 / 10:16 The issuer is solely responsible ... Seite 1

DGAP-News: Eckert & Ziegler to Supply Telix with Lutetium-177 for Clinical Trials Seite 1 - Vimarsana News

DGAP-News: Eckert & Ziegler to Supply Telix with Lutetium-177 for Clinical Trials Seite 1

09.02.2022 - DGAP-News: Eckert & Ziegler Strahlen- und Medizintechnik AG / Key word(s): Incoming Orders/Agreement Eckert & Ziegler to Supply Telix with Lutetium-177 for Clinical Trials 09.02.2022 / 07:45 The issuer is solely responsible for the content of ... Seite 1